- Home
- IQV vs DD Comparison
IQV vs DD Comparison
Compare IQV & DD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IQV | DD |
|---|---|---|
| Founded | 1982 | 2015 |
| Country | United States | United States |
| Employees | 93000 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.3B | 20.2B |
| IPO Year | 2013 | 2016 |
Fundamental Metrics
Financial Performance| Metric | IQV | DD |
|---|---|---|
| Price | $164.74 | $44.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 14 |
| Target Price | ★ $230.56 | $62.07 |
| AVG Volume (30 Days) | 2.4M | ★ 3.6M |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 1.76% |
| EPS Growth | ★ 4.67 | N/A |
| EPS | ★ 7.84 | N/A |
| Revenue | $9,739,000,000.00 | ★ $20,397,000,000.00 |
| Revenue This Year | $6.76 | $6.91 |
| Revenue Next Year | $5.85 | $3.85 |
| P/E Ratio | $20.74 | ★ N/A |
| Revenue Growth | ★ 41.60 | N/A |
| 52 Week Low | $134.65 | $33.34 |
| 52 Week High | $247.05 | $83.40 |
Technical Indicators
Market Signals| Indicator | IQV | DD |
|---|---|---|
| Relative Strength Index (RSI) | 36.48 | 37.87 |
| Support Level | $156.43 | $42.47 |
| Resistance Level | $166.38 | $52.66 |
| Average True Range (ATR) | 6.33 | 1.31 |
| MACD | 1.34 | -0.68 |
| Stochastic Oscillator | 20.98 | 20.41 |
Price Performance
Historical ComparisonAbout IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
About DD DuPont de Nemours Inc.
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the healthcare, water, construction, automotive, aerospace, and printing and packaging industries. Healthcare and water will generate the majority of profits.